Screener
ANI Pharmaceuticals ANIP Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: ANI Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001023024-26-000069
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Inventories | 143,149 | 143,067 |
| Prepaid expenses and other current assets | 31,942 | 34,216 |
| Investment in equity securities | 15,626 | 9,131 |
| Total Current Assets | 825,433 | 753,117 |
| Non-current Assets | ||
| Property and equipment, net | 73,223 | 62,476 |
| Deferred tax assets, net | 71,495 | 69,072 |
| Intangible assets, net | 449,857 | 479,526 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is ANI Pharmaceuticals's total current assets?
- ANI Pharmaceuticals (ANIP) reported total current assets of $825.43M in Q2 2026.
- How has ANI Pharmaceuticals's total current assets changed year-over-year?
- ANI Pharmaceuticals's total current assets increased by 37.0% year-over-year, from $602.63M to $825.43M.
- What is the long-term trend for ANI Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), ANI Pharmaceuticals's total current assets has grown at a 34.6% compound annual growth rate (CAGR), from $170.32M to $753.12M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about ANI Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude